NRx Pharmaceuticals
NRXP

NRx Pharmaceuticals (NRXP) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$45.00Aug 25, 2026
BTIGMaintainedBuy$10.00Aug 18, 2026
BTIGMaintainedBuy$10.00 from $25.00Aug 7, 2026
D. Boral CapitalMaintainedBuy$34.00May 5, 2026
Ascendiant CapitalMaintainedBuy$49.00 from $48.00Apr 27, 2026
HC Wainwright & Co.MaintainedBuy$45.00Apr 27, 2026
D. Boral CapitalMaintainedBuy$34.00Apr 23, 2026
D. Boral CapitalMaintainedBuy$34.00Apr 20, 2026
BTIGMaintainedBuy$25.00Mar 24, 2026
D. Boral CapitalMaintainedBuy$34.00Mar 24, 2026
D. Boral CapitalMaintainedBuy$34.00Mar 17, 2026
D. Boral CapitalMaintainedBuy$34.00Mar 16, 2026
D. Boral CapitalMaintainedBuy$34.00Mar 9, 2026
HC Wainwright & Co.MaintainedBuy$45.00 from $40.00Mar 3, 2026
BTIGMaintainedBuy$25.00Feb 18, 2026
D. Boral CapitalMaintainedBuy$34.00Feb 17, 2026
BTIGMaintainedBuy$25.00Jan 15, 2026
D. Boral CapitalMaintainedBuy$34.00Jan 5, 2026
Ascendiant CapitalMaintainedBuy$48.00 from $47.00Jan 2, 2026
HC Wainwright & Co.MaintainedBuy$40.00Dec 16, 2025

Frequently asked questions

  • What is the latest analyst rating on NRXP?

    On Aug 25, 2026, HC Wainwright & Co. maintained NRx Pharmaceuticals at Buy with a price target of $45.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.